Hangzhou Tigermed Consulting (03347) spent 2.2259 million yuan on February 11 to repurchase 42,000 A-shares.
Tiger Pharmaceuticals (03347) announced that on February 11, 2025, the company invested 222.59 million RMB...
Hangzhou Tigermed Consulting (03347) announced that on February 11, 2025, the company will spend 2.2259 million yuan to repurchase 42,000 A-shares at a repurchase price of 52.98-53.00 yuan per share.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


